© news18.comDays after advising booster dose, INSACOG says more experiments needed to assess impact
Days after favouring a booster dose of Covid-19 vaccine for people above 40 years, the country's top genome sequencing laboratories on Saturday said their recommendation was not for the national immunisation programme as many more scientific experiments are required to assess its impact.
In a bulletin issued on Saturday, the Indian SARS-CoV-2 Consortium on Genomics (INSACOG) said the mention of the booster dose in its previous bulletin was merely a “discussion about the potential role of additional dose of Covid-19 vaccines in high-risk populations”.
"Many more scientific experiments are needed to assess the impacts of booster dose, which are being guided and monitored by National Technical Advisory Group on Immunization (NTAGI) and National Expert Group on Vaccine Administration for Covid-19 (NEGVAC),” said the INSACOG bulletin dated December 4.